Definium Therapeutics, Inc. (DFTX)
23.45
+1.05
(+4.69%)
USD |
NASDAQ |
May 06, 16:00
23.38
-0.07
(-0.30%)
After-Hours: 20:00
Definium Therapeutics Total Liabilities (Quarterly) : 107.77M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Atai Beckley, Inc. | 88.54M |
| Plus Therapeutics, Inc. | 12.33M |
| Viridian Therapeutics, Inc. | -- |
| Nutriband, Inc. | 0.8684M |
| Immunovant, Inc. | 66.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 440.10M |
| Shareholders Equity (Quarterly) | 332.33M |
| Debt to Equity Ratio | 0.1221 |
| Current Ratio | 6.287 |
| Net Debt Paydown Yield | -0.25% |